These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 10513053)

  • 1. Persistence of Leishmania antigen in C57Bl/6j inbred mice infected with Leishmania (Leishmania) amazonensis.
    Vasconcellos C; Kauffman MR; Sotto MN
    Rev Assoc Med Bras (1992); 1999; 45(3):225-8. PubMed ID: 10513053
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Salivary gland homogenates from wild-caught sand flies Lutzomyia flaviscutellata and Lutzomyia (Psychodopygus) complexus showed inhibitory effects on Leishmania (Leishmania) amazonensis and Leishmania (Viannia) braziliensis infection in BALB/c mice.
    Francesquini FC; Silveira FT; Passero LF; Tomokane TY; Carvalho AK; Corbett CE; Laurenti MD
    Int J Exp Pathol; 2014 Dec; 95(6):418-26. PubMed ID: 25476864
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification and purification of a 72 kDa antigen of Leishmania braziliensis braziliensis present on the surface and in the cytoplasm of the promastigotes and its specific recognition by sera from mucocutaneous leishmaniasis patients.
    Kutner S; Pellerin P; Brenière SF; Desjeux P; Dedet JP
    Mem Inst Oswaldo Cruz; 1988 Nov; 83 Suppl 1():431-4. PubMed ID: 3253506
    [No Abstract]   [Full Text] [Related]  

  • 4. Development of metacyclic Leishmania promastigotes is associated with the increasing expression of GP65, the major surface antigen.
    Kweider M; Lemesre JL; Santoro F; Kusnierz JP; Sadigursky M; Capron A
    Parasite Immunol; 1989 May; 11(3):197-209. PubMed ID: 2771426
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biological behavior of Leishmania amazonensis isolated from humans with cutaneous, mucosal, or visceral leishmaniasis in BALB/C mice.
    Almeida RP; Barral-Netto M; De Jesus AM; De Freitas LA; Carvalho EM; Barral A
    Am J Trop Med Hyg; 1996 Feb; 54(2):178-84. PubMed ID: 8619444
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Leishmania (viannia) panamensis-induced cutaneous leishmaniasis in susceptible and resistant mouse strains.
    Goto H; Rojas JI; Sporrong L; De Carreira P; Sánchez C; Orn A
    Rev Inst Med Trop Sao Paulo; 1995; 37(6):475-81. PubMed ID: 8731258
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Role of three ELISA tests using promastigote homogenates of Leishmania braziliensis, L. amazonensis and L. guyanensis in the diagnosis of tegumentary leishmaniasis].
    Gil JF; Hoyos CL; Cimino RO; Krolewiecki AJ; López Quiroga I; Cajal SP; Juárez M; García Bustos MF; Mora MC; Marco JD; Nasser JR
    Medicina (B Aires); 2011; 71(5):420-8. PubMed ID: 22057166
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Histopathological studies of visceralized Leishmania (Leishmania) amazonensis in mice experimentally infected.
    Abreu-Silva AL; Calabrese KS; Cupolilo SM; Cardoso FO; Souza CS; Gonçalves da Costa SC
    Vet Parasitol; 2004 May; 121(3-4):179-87. PubMed ID: 15135858
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of vaccination with a combination of Leishmania amastigote antigens and the lipid A-analogue ONO-4007 for immunoprophylaxis and immunotherapy against Leishmania amazonensis infection in a murine model of New World cutaneous leishmaniasis.
    Calvopina M; Barroso PA; Marco JD; Korenaga M; Cooper PJ; Nonaka S; Hashiguchi Y
    Vaccine; 2006 Jul; 24(27-28):5645-52. PubMed ID: 16621179
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low and high-dose intradermal infection with Leishmania major and Leishmania amazonensis in C57BL/6 mice.
    Côrtes DF; Carneiro MB; Santos LM; Souza TC; Maioli TU; Duz AL; Ramos-Jorge ML; Afonso LC; Carneiro C; Vieira LQ
    Mem Inst Oswaldo Cruz; 2010 Sep; 105(6):736-45. PubMed ID: 20944986
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Presentation of the protective parasite antigen LACK by Leishmania-infected macrophages.
    Prina E; Lang T; Glaichenhaus N; Antoine JC
    J Immunol; 1996 Jun; 156(11):4318-27. PubMed ID: 8666803
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inbred mice as model hosts for cutaneous leishmaniasis. I. Resistance and susceptibility to infection with Leishmania braziliensis, L. mexicana, and L. aethiopica.
    Childs GE; Lightner LK; McKinney L; Groves MG; Price EE; Hendricks LD
    Ann Trop Med Parasitol; 1984 Feb; 78(1):25-34. PubMed ID: 6721612
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential interferon- gamma production characterizes the cytokine responses to Leishmania and Mycobacterium leprae antigens in concomitant mucocutaneous leishmaniasis and lepromatous leprosy.
    Matos DS; Azeredo-Coutinho RB; Schubach A; Conceição-Silva F; Baptista C; Moreira JS; Mendonça SC
    Clin Infect Dis; 2005 Jan; 40(2):e5-12. PubMed ID: 15655736
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Frequency of Leishmania-reactive T cells in lesions of American mucocutaneous leishmaniasis (AMCL) patients. Its relevance in the process of healing or aggravation of the disease.
    Conceição-Silva F; Dórea R; Pirmez C; Schubach AO; Cysne L; Coutinho SG
    Mem Inst Oswaldo Cruz; 1988 Nov; 83 Suppl 1():403-6. PubMed ID: 3267032
    [No Abstract]   [Full Text] [Related]  

  • 15. A case of mucocutaneous leishmaniasis diagnosed by serology.
    Okumura Y; Yamauchi A; Nagano I; Itoh M; Hagiwara K; Takahashi K; Uezato H; Maeda M; Seishima M
    J Dermatol; 2014 Aug; 41(8):739-42. PubMed ID: 25041360
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Testing of four Leishmania vaccine candidates in a mouse model of infection with Leishmania (Viannia) braziliensis, the main causative agent of cutaneous leishmaniasis in the New World.
    Salay G; Dorta ML; Santos NM; Mortara RA; Brodskyn C; Oliveira CI; Barbiéri CL; Rodrigues MM
    Clin Vaccine Immunol; 2007 Sep; 14(9):1173-81. PubMed ID: 17626159
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of intranasal LaAg vaccine against Leishmania amazonensis infection in partially resistant C57Bl/6 mice.
    Pratti JE; Ramos TD; Pereira JC; da Fonseca-Martins AM; Maciel-Oliveira D; Oliveira-Silva G; de Mello MF; Chaves SP; Gomes DC; Diaz BL; Rossi-Bergmann B; de Matos Guedes HL
    Parasit Vectors; 2016 Oct; 9(1):534. PubMed ID: 27716449
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Experimental cutaneous leishmaniasis: transmission electron microscopy of the inoculation site.
    Vasconcellos C; Sotto MN
    Int J Exp Pathol; 1997 Apr; 78(2):81-9. PubMed ID: 9203982
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Histopathology of tegumentary leishmaniasis caused by Leishmania braziliensis braziliensis. 2. Tissue humoral response].
    de Magalhães AV; Moraes MA; Raick AN; Llanos-Cuentas A; Costa JM; Cuba CC; Marsden PD
    Rev Inst Med Trop Sao Paulo; 1986; 28(5):293-9. PubMed ID: 3296117
    [No Abstract]   [Full Text] [Related]  

  • 20. Early infection with Leishmania major restrains pathogenic response to Leishmania amazonensis and parasite growth.
    González-Lombana CZ; Santiago HC; Macedo JP; Seixas VA; Russo RC; Tafuri WL; Afonso LC; Vieira LQ
    Acta Trop; 2008 Apr; 106(1):27-38. PubMed ID: 18313021
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.